Castle Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference
Castle Biosciences (Nasdaq: CSTL), a company specializing in innovative health tests for patient care, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The company's executive management is scheduled to present a company overview on Tuesday, Aug. 13, 2024, at 12:30 p.m. Eastern time.
Investors and interested parties can access a live audio webcast of the presentation through Castle Biosciences' website at ir.castlebiosciences.com/events-presentations/. For those unable to attend the live event, a replay of the webcast will be made available after the presentation concludes.
Castle Biosciences (Nasdaq: CSTL), un'azienda specializzata in test sanitari innovativi per la cura dei pazienti, ha annunciato la sua partecipazione alla 44a Conferenza Annuale di Crescita di Canaccord Genuity. La direzione esecutiva dell'azienda presenterà una panoramica aziendale martedì 13 agosto 2024, alle 12:30 ora orientale.
Gli investitori e le parti interessate possono accedere a un webcast audio in diretta della presentazione attraverso il sito web di Castle Biosciences all'indirizzo ir.castlebiosciences.com/events-presentations/. Per coloro che non possono partecipare all'evento dal vivo, sarà disponibile un ripristino del webcast dopo la conclusione della presentazione.
Castle Biosciences (Nasdaq: CSTL), una empresa especializada en pruebas de salud innovadoras para el cuidado de pacientes, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity. La gestión ejecutiva de la empresa tiene programada una presentación sobre la compañía el martes 13 de agosto de 2024, a las 12:30 p.m. hora del Este.
Los inversores y partes interesadas pueden acceder a un webcast de audio en vivo de la presentación a través del sitio web de Castle Biosciences en ir.castlebiosciences.com/events-presentations/. Para aquellos que no puedan asistir al evento en vivo, se hará disponible una repetición del webcast una vez concluida la presentación.
Castle Biosciences (Nasdaq: CSTL)는 환자 치료를 위한 혁신적인 건강 테스트를 전문으로 하는 회사로, 캐나다 세무사 제44회 연례 성장 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사의 경영진은 2024년 8월 13일 화요일 오후 12:30 동부 표준시에 회사 개요를 발표할 예정입니다.
투자자 및 관심 있는 분들은 Castle Biosciences의 웹사이트 ir.castlebiosciences.com/events-presentations/를 통해 실시간 오디오 웹캐스트에 접근할 수 있습니다. 실시간 이벤트에 참석할 수 없는 분들을 위해 발표 종료 후 웹캐스트 재방송이 제공될 예정입니다.
Castle Biosciences (Nasdaq: CSTL), une entreprise spécialisée dans les tests de santé innovants pour le soin des patients, a annoncé sa participation à la 44e Conférence Annuelle sur la Croissance de Canaccord Genuity. La direction de l'entreprise doit présenter un aperçu de la société le mardi 13 août 2024, à 12h30 heure de l'Est.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire audio en direct de la présentation via le site web de Castle Biosciences à l'adresse ir.castlebiosciences.com/events-presentations/. Pour ceux qui ne peuvent pas assister à l'événement en direct, une rediffusion du webinaire sera proposée après la conclusion de la présentation.
Castle Biosciences (Nasdaq: CSTL), ein Unternehmen, das auf innovative Gesundheitstests für die Patientenversorgung spezialisiert ist, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity bekannt gegeben. Das Management des Unternehmens wird am Dienstag, den 13. August 2024, um 12:30 Uhr Eastern Time eine Unternehmensübersicht präsentieren.
Investoren und interessierte Parteien können über die Website von Castle Biosciences unter ir.castlebiosciences.com/events-presentations/ auf einen live Audio-Webcast der Präsentation zugreifen. Für diejenigen, die nicht an der Live-Veranstaltung teilnehmen können, wird nach dem Ende der Präsentation ein Wiedergabe des Webcasts zur Verfügung gestellt.
- None.
- None.
A live audio webcast of the Company’s presentation will be available by visiting Castle Biosciences’ website at ir.castlebiosciences.com/events-presentations/. A replay of the webcast will be available following the conclusion of the live broadcast.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240730290206/en/
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
FAQ
When is Castle Biosciences (CSTL) presenting at the Canaccord Genuity Growth Conference?
How can I watch Castle Biosciences' (CSTL) presentation at the Canaccord Genuity conference?
Will there be a replay available of Castle Biosciences' (CSTL) presentation at the Canaccord Genuity conference?
What type of presentation will Castle Biosciences (CSTL) give at the Canaccord Genuity conference?
